Abstract
Purpose
This study aims to assess the vision-related quality of life in patients with retinal vein occlusion (RVO) among those referred to Labbafinejad Medical Center and Imam Hossein Hospital between 2019 and 2021.
Methods
This comparative study included 37 eligible patients diagnosed with various types of RVO, with an average age of 61 ± 9. To ensure data validity, we included 74 age- and sex-matched healthy individuals. Only cases with a definitive diagnosis of RVO, confirmed by two retina specialists (ND and RN), were included. We assessed the vision-related quality of life of our participants using the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25). All participants underwent interviews.
Results
In our study, we examined the vision-related quality of life in different subgroups of RVO patients. Overall, RVO patients had a significantly lower total VRQoL score compared to healthy individuals (P < 0.001), except in the subscale analysis of specific factors such as ocular pain, color vision, and driving, where no statistically significant difference was observed. A statistically significant difference was found in the comparison of subgroups, indicating lower VRQoL in central retinal vein occlusion (CRVO) patients (P = 0.010). Furthermore, a significant correlation was observed between lower VRQoL and decreased vision (P = 0.009) as well as longer disease duration (P = 0.011).
Conclusion
Retinal vein occlusion can significantly reduce vision-related quality of life, particularly in more severe cases.
Similar content being viewed by others
Availability of data and materials
The data generated or analyzed during this study are not included in this article but can be made available upon request from the corresponding author.
References
Laouri M, Chen E, Looman M, Gallagher M (2011) The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond) 25(8):981–988
Ip M, Hendrick A (2018) Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila) 7(1):40–45
Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33(2):111–131
The Eye Disease Case-control Study Group (1993) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116(3):286–296
Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the beaver dam eye study. Trans Am Ophthalmol Soc 98:133–141 (discussion 141–3)
Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131(1):61–77
Martin SC, Butcher A, Martin N, Farmer J, Dobson PM, Bartlett WA et al (2002) Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86(7):774–776
Hu CC, Ho JD, Lin HC (2009) Retinal vein occlusion and the risk of acute myocardial infarction (correction of infraction): a 3-year follow-up study. Br J Ophthalmol 93(6):717–720
Song P, Xu Y, Zha M, Zhang Y, Rudan I (2019) Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health 9(1):010427
Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE et al (2005) Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology 112(4):540–547
Yasuda M, Kiyohara Y, Arakawa S, Hata Y, Yonemoto K, Doi Y et al (2010) Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 51(6):3205–3209
Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW et al (2010) Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117(6):1094-1101.e5
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD et al (2001) Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 119(7):1050–1058
Asgari S, Hashemi H, Nedjat S, Shahnazi A, Fotouhi A (2011) Persian version of the 25-item national eye institute visual functioning questionnaire (NEI-VFQ25): a validaton study. Iran J Ophthalmol 23(3):5–14
Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM (2001) The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 119(5):733–740
Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P (2010) Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 51(2):712–717
Kumar S, Thakur S, Ichhpujani P (2019) The impact of primary open-angle glaucoma: comparison of vision-specific (national eye institute visual function questionnaire-25) and disease-specific (glaucoma quality of life-15 and viswanathan 10) patient-reported outcome (PRO) instruments. Indian J Ophthalmol 67(1):83–88
Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ (1999) Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 128(1):54–62
Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S (2003) Vision-related quality of life in people with central retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 121(9):1297–1302
Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S (2010) Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Br J Ophthalmol 94(3):319–323
Prem Senthil M, Khadka J, Gilhotra JS, Simon S, Fenwick EK, Lamoureux E, Pesudovs K (2019) Understanding quality of life impact in people with retinal vein occlusion: a qualitative inquiry. Clin Exp Optom 102(4):406–411
Okamoto F, Tomioka M, Murakami T, Morikawa S, Sugiura Y, Hiraoka T et al (2021) Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion. Sci Rep 11(1):20475
Murakami T, Okamoto F, Sugiura Y, Morikawa S, Okamoto Y, Hiraoka T et al (2022) visual functions affecting vision-related quality of life following intravitreal ranibizumab therapy for central retinal vein occlusion. J Clin Med 11(14):4139
Bonomi AE, Patrick DL, Bushnell DM, Martin M (2000) Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol 53(1):1–12
Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investig Arch Ophthalmol 116(11):1496–1504
Dandona L, Dandona R (2006) Revision of visual impairment definitions in the international statistical classification of diseases. BMC Med 4:7
Behboudi H, Nikkhah H, Alizadeh Y, Katibeh M, Pakbin M, Ahmadieh H et al (2020) A Population-based study on the prevalence and associated factors of age-related macular degeneration in northern iran the gilan eye study. Ophthalmic Epidemiol 27(3):209–218
Husten CG (2009) How should we define light or intermittent smoking? Does it matter? Nicotine Tob Res 11(2):111–121
Katibeh M, Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H (2020) Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J 26(3):304–314
Fujiwara T, Yano Y, Hoshide S, Kanegae H, Kario K (2018) Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a japanese general practice population. JAMA Cardiol 3(7):583–590
Acknowledgements
The listed authors have approved all statements and declarations, including any conflicting interests, funding disclosures, etc.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study's conception and design. Patient examinations were conducted by HS, SR, RN, ND, and HA. The manuscript was written by HS, FR, KS and SR. Data collection was carried out by HS, FR, and AA. Data analysis was performed by BK and KS. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
All experimental protocols received approval from the Ethics Committee of the Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, under approval number IR.SBMU.ORC.REC.1400.007. All methods adhered to the guidelines and regulations outlined in the Declaration of Helsinki. Informed consent letters were obtained from all study participants, as well as from their parents or legal guardians. Participants were assured that their information would be kept confidential.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ramin, S., Rostami, F., Ahmadieh, H. et al. Vision-related quality of life in patients with retinal vein occlusion. Int Ophthalmol 44, 114 (2024). https://doi.org/10.1007/s10792-024-02916-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-02916-1